ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers.

Fenne L Komdeur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.